Protein–protein interaction (PPI), survival analysis and diagnostic value assessment help us identify key genes associated with BRCA1/2 mutations and provide new insights for the specific mechanisms and treatment targets research of BRCA-mutant breast cancer different from other breast cancers. This evidence concerns the gene BRCA1 and breast cancer.